BCOR and neoplasm: Further BCOR variants were found in a PB-miRNA2 case with a homozygous DROSHA deletion (BCOR S17R; VAF = 100%, uncertain significance of pathogenity) and in a PB-miRNA1A tumor with a heterozygous DROSHA mutation (BCOR P120 frameshift deletion; VAF = 18%).